The Osteosarcoma Institute (OSI) has awarded over $1.5 million in research funding to four projects aiming to advance the treatment of osteosarcoma. The OSI, which works to increase treatment options and survival rates in osteosarcoma patients, has awarded sums between $125,000 and $500,000 to projects in the field. OSI Director Dr Lee Helman cited the decrease in funding […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!